Split, Croatia: CBD dosing reduces blood pressure in patients suffering from hypertension, according to clinical trial data published in the European Heart Journal.
Seventy patients diagnosed with high blood pressure consumed either CBD or a placebo for five weeks.
Researchers documented reductions in patients’ systolic and diastolic blood pressure readings following CBD dosing. No similar reductions occurred following the use of the placebo.
“[These] results indicate that chronic CBD supplementation leads to blood pressure reduction,” the study’s authors concluded.
The finding is consistent with those of other clinical trials “demonstrating a significant reduction in systolic blood pressure after acute cannabidiol.”
A prior analysis of more than 91,000 French adults, published in the journal Nature: Scientific Reports, similarly determined that current and lifetime cannabis use is associated with lower blood pressure.
Another study, published in the European Journal of Internal Medicine, concludes that the use of medical cannabis products is associated with decreases in hypertension among elderly subjects.
Full text of the study, “The effects of chronic cannabidiol dosing on cardiovascular parameters in primary hypertension: A summary of findings from a randomized controlled trial,” appears in the European Heart Journal.